| Title |
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
|
|---|---|
| Published in |
New England Journal of Medicine, November 2020
|
| DOI | 10.1056/nejmoa2022483 |
| Pubmed ID | |
| Authors |
Lisa A. Jackson, Evan J. Anderson, Nadine G. Rouphael, Paul C. Roberts, Mamodikoe Makhene, Rhea N. Coler, Michele P. McCullough, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. Pruijssers, Adrian McDermott, Britta Flach, Nicole A. Doria-Rose, Kizzmekia S. Corbett, Kaitlyn M. Morabito, Sijy O’Dell, Stephen D. Schmidt, Phillip A. Swanson, Marcelino Padilla, John R. Mascola, Kathleen M. Neuzil, Hamilton Bennett, Wellington Sun, Etza Peters, Mat Makowski, Jim Albert, Kaitlyn Cross, Wendy Buchanan, Rhonda Pikaart-Tautges, Julie E. Ledgerwood, Barney S. Graham, John H. Beigel |
Twitter Demographics
The data shown below were collected from the profiles of 14,948 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2014 | 13% |
| Mexico | 1596 | 11% |
| Spain | 420 | 3% |
| Argentina | 338 | 2% |
| Japan | 264 | 2% |
| United Kingdom | 216 | 1% |
| Colombia | 175 | 1% |
| Guatemala | 162 | 1% |
| India | 156 | 1% |
| Other | 2164 | 14% |
| Unknown | 7443 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13216 | 88% |
| Scientists | 958 | 6% |
| Practitioners (doctors, other healthcare professionals) | 569 | 4% |
| Science communicators (journalists, bloggers, editors) | 198 | 1% |
| Unknown | 7 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 3,755 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3755 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 583 | 16% |
| Researcher | 470 | 13% |
| Student > Ph. D. Student | 341 | 9% |
| Student > Master | 324 | 9% |
| Other | 248 | 7% |
| Other | 610 | 16% |
| Unknown | 1179 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 735 | 20% |
| Biochemistry, Genetics and Molecular Biology | 505 | 13% |
| Immunology and Microbiology | 245 | 7% |
| Agricultural and Biological Sciences | 211 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 154 | 4% |
| Other | 578 | 15% |
| Unknown | 1327 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13919. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2023.
All research outputs
#84
of 24,514,423 outputs
Outputs from New England Journal of Medicine
#9
of 31,901 outputs
Outputs of similar age
#5
of 420,714 outputs
Outputs of similar age from New England Journal of Medicine
#2
of 275 outputs
Altmetric has tracked 24,514,423 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,901 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 121.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,714 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 275 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.